Tru St Partnership, L.P. 的 Form 4 申報
Integra Lifesciences Holdings CorpIART，2022/3/25 申報
- 申報編號
- 0000899243-22-012345
- 申報時間
- 2022/3/25
- 交易日
- 2021/12/16-2022/3/23
- 申報延遲
- 99 天遲報
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $1,946 萬。交易後 99 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Tru St Partnership, L.P.CIK 0001824663 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.28 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $65.82 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The reporting person contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $64.67 per share for purposes of determining the number of shares of the exchange fund issuable to Trust Partnership.
表 I 有 1 筆交易的價格引用這則附註。
備註
President, Chief Executive Officer and Chairman of the Board